Sintx Technologies (SINT) Property, Plant & Equipment (Net) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 10.07% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.71% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 17.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.47% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 13.19% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.97% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 9.80% |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | -58.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.42% |
| Dec 31, 2025 | -56.27% |
| Sep 30, 2025 | -54.81% |
| Jun 30, 2025 | -53.87% |
| Mar 31, 2025 | -48.40% |
| Dec 31, 2024 | -38.81% |
| Sep 30, 2024 | -34.99% |
| Jun 30, 2024 | 67.31% |
| Mar 31, 2024 | 100.42% |
| Dec 31, 2023 | 117.20% |
| Sep 30, 2023 | 167.64% |
| Jun 30, 2023 | 189.88% |
| Mar 31, 2023 | 209.87% |
| Dec 31, 2022 | 210.56% |
| Sep 30, 2022 | 198.27% |
| Jun 30, 2022 | 288.08% |
| Mar 31, 2022 | 250.76% |
| Dec 31, 2021 | 218.99% |
| Sep 30, 2021 | 194.06% |
| Jun 30, 2021 | -5.34% |
| Mar 31, 2021 | -22.13% |
| Dec 31, 2020 | 29.28% |
| Sep 30, 2020 | -40.64% |
| Mar 31, 2020 | -42.47% |
| Dec 31, 2019 | -40.21% |
| Sep 30, 2019 | -51.51% |
| Jun 30, 2019 | -65.34% |
| Dec 31, 2018 | -63.12% |
| Sep 30, 2018 | -61.69% |
| Jun 30, 2018 | -26.15% |
| Mar 31, 2018 | -25.99% |
| Dec 31, 2017 | -60.42% |
| Sep 30, 2017 | -30.28% |
| Mar 31, 2017 | -34.49% |
| Dec 31, 2016 | -36.86% |